Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) induces proliferation and sustains viability of the mouse interleukin (IL)-3 dependent lymphoid cell line BA/F3 expressing the hGM-CSF receptor. Caspase-3 like enzyme activity and DNA fragmentation were augmented by depletion of this factor from the cell, and exposure to g irradiation accelerated kinetics of these events. Anti g irradiationinduced apoptosis occurred through various mutant GM-CSF receptors and only the box1 region was essential while the C terminal region, including tyrosine residues which are required for MAPK cascade activation, was dispensable. Consistent with this notion, the addition of PD98059 had no e ect on this activity thereby indicating that activation of MAPK is not essential for the activity. As expected, g irradiation increased p53 protein and bax mRNA levels and the presence of hGM-CSF dramatically modulated bax/bcl-X L ratio. The PI-3K speci®c inhibitor wortmannin did not a ect hGM-CSF dependent anti g irradiation induced apoptosis nor bcl-X L induction, thus bcl-X L but not PI-3K pathway seems to be involved in hGM-CSF dependent anti g irradiation-induced apoptosis. It is well documented that the box1 region is essential for GM-CSF dependent activation of JAK2 and JAK2 speci®c inhibitor AG490 suppressed anti g irradiation-induced apoptosis by hGM-CSF. An arti®cial JAK2 activating molecule in which extracellular and the transmembrane of bc fused with whole JAK2 can sustain BA/F3 cells survival and proliferation mIL-3 independently, but these cells are susceptible to g irradiation. Furthermore GyrB/Jak2, which can activate STAT5 but not the MAPK cascade nor survival of BA/F3 cells, also could not prevent g irradiation-induced apoptosis. Although JAK2 is essential for hGM-CSF dependent anti g irradiation-induced apoptosis, it appeared that JAK2 does not seem su cient for the activity. Oncogene (2000) 19, 571 ± 579.